Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q4 2023
Institutional positions in Revolution Medicines, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 184
- +18 vs. Q3 2023
- Shares held
- 160.0M
- +47.6M (+42.4%) vs. Q3 2023
- Total value
- $4.59B
- +$1.48B (+47.5%) vs. Q3 2023
- New holders
- 54
- 81 more added
- Sold out
- 36
- 34 more reduced
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −21,071−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −20,805−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,143−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −15,209−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,457−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −10,758−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −10,662−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −10,432−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −7,435−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −7,321−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −4,601−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −4,547−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −4,542−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −3,250−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −192−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Tfo-TDC, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| First Republic Investment Management, Inc. | – | – | – | – | Not filed |
| Steward Financial Group LLC | – | – | – | – | Not filed |